Semaglutide pill vs injection
Oral semaglutide (Rybelsus, Wegovy pill) and semaglutide (Ozempic, Wegovy). What the research says about each, side by side. Every row comes from the studies and drug labels in the last row. More on each: Oral semaglutide and Semaglutide.
| Oral semaglutide | Semaglutide | |
|---|---|---|
| Category | GLP-1 and metabolic | GLP-1 and metabolic |
| Evidence | Extensive clinical research | Extensive clinical research |
| FDA status | FDA-approved as Rybelsus (2019, type 2 diabetes) and as the Wegovy pill (December 2025, weight management and heart risk). The labels say: take it in the morning on an empty stomach with up to 4 oz of water, then wait at least 30 minutes before eating, drinking or taking other pills. | FDA-approved as Ozempic (2017), Rybelsus (2019) and Wegovy (2021). Wegovy was also approved for lowering heart attack and stroke risk in 2024. Compounded copies aren't FDA-approved. |
| How it works | It switches on GLP-1 receptors in the pancreas, gut and brain, like the shots: more insulin when blood sugar is high, a slower stomach and quieter hunger. The tablet dissolves in the stomach, so food, drinks or other pills taken too soon block most of the dose from getting in. | It switches on GLP-1 receptors in the pancreas, gut and brain. That helps the pancreas release insulin when blood sugar is high, slows how fast the stomach empties, and quiets hunger signals in the brain, so people feel full sooner and think about food less. |
| Half-life | About 7 days, like the shots, so daily pills build to a steady level over 4 to 5 weeks. Levels peak about an hour after each tablet. | About 7 days, so weekly shots build to a steady level after 4–5 weeks. Levels peak 1–3 days after a shot. The daily pill peaks about an hour after taking it. |
| Studied for |
|
|
| Reported side effects |
|
|
| Sources |
|
|
